Zealand Pharma Completes Patient Enrollment In Phase 3 Trial Of Dasiglucagon In Children With Congenital Hyperinsulinism

Zealand Pharma Completes Patient Enrollment In Phase 3 Trial Of Dasiglucagon In Children With Congenital Hyperinsulinism

By, Admin 16 February 2022

Zealand Pharma A/S, A Biotechnology Company Focused On The Discovery, Development And Commercialization Of Innovative Peptide-Based Medicines, Announced Completion Of Patient Enrollment In The Second Phase 3-Trial, 17103, Of Dasiglucagon For The Treatment Of Congenital Hyperinsulinism (Chi) In Neonates Up To 12 Months Old. This Phase 3 Study Is The Last In The Program Which Constitute The Largest Clinical Development Programme Ever Conducted In Chi.Chi Is The Most Frequent Cause Of Severe And Persistent Hypoglycemia. It Starts As Early As The Neonatal Period And Profoundly Affects Those Children And Their Families Through Infancy And Teenage Years. It Is Characterized By An Excessive And Uncontrolled Insulin Secretion Triggering Recurrent Episodes Of Profound Hypoglycemia Which Require Constant Surveillance And Rapid And Intensive Interventions To Prevent Neurological Sequelae.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!